180 related articles for article (PubMed ID: 32392725)
1. Outcomes of Patients with Clinical Stage I-IIIA Large-Cell Neuroendocrine Lung Cancer Treated with Resection.
Lowczak A; Kolasinska-Cwikla A; Ćwikła JB; Osowiecka K; Palucki J; Rzepko R; Glinka L; Doboszyńska A
J Clin Med; 2020 May; 9(5):. PubMed ID: 32392725
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of Patients with Pulmonary Large Cell Neuroendocrine Carcinoma in I-IV Stage.
Lowczak A; Kolasinska-Cwikla A; Osowiecka K; Glinka L; Palucki J; Rzepko R; Doboszynska A; Cwikla JB
Medicina (Kaunas); 2021 Jan; 57(2):. PubMed ID: 33525370
[No Abstract] [Full Text] [Related]
3. Adjuvant Therapy for Patients With Early Large Cell Lung Neuroendocrine Cancer: A National Analysis.
Raman V; Jawitz OK; Yang CJ; Tong BC; D'Amico TA; Berry MF; Harpole DH
Ann Thorac Surg; 2019 Aug; 108(2):377-383. PubMed ID: 31004586
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant and adjuvant chemotherapy in resected pulmonary large cell neuroendocrine carcinomas: a single institution experience.
Sarkaria IS; Iyoda A; Roh MS; Sica G; Kuk D; Sima CS; Pietanza MC; Park BJ; Travis WD; Rusch VW
Ann Thorac Surg; 2011 Oct; 92(4):1180-6; discussion 1186-7. PubMed ID: 21867986
[TBL] [Abstract][Full Text] [Related]
5. Recurrence-Free Survival in Early and Locally Advanced Large Cell Neuroendocrine Carcinoma of the Lung after Complete Tumor Resection.
Altieri B; La Salvia A; Modica R; Marciello F; Mercier O; Filosso PL; de Latour BR; Giuffrida D; Campione S; Guggino G; Fadel E; Papotti M; Colao A; Scoazec JY; Baudin E; Faggiano A
J Pers Med; 2023 Feb; 13(2):. PubMed ID: 36836564
[TBL] [Abstract][Full Text] [Related]
6. Clinical and Pathologic Differences between Small-Cell Carcinoma and Large-Cell Neuroendocrine Carcinoma of the Lung.
Fujiwara W; Yotsukura M; Yoshida Y; Nakagawa K; Kashima J; Yatabe Y; Watanabe SI
Ann Surg Oncol; 2024 May; ():. PubMed ID: 38811497
[TBL] [Abstract][Full Text] [Related]
7. The Role of Systemic Therapy in the Management of Stage I Large Cell Neuroendocrine Carcinoma of the Lung.
Kujtan L; Muthukumar V; Kennedy KF; Davis JR; Masood A; Subramanian J
J Thorac Oncol; 2018 May; 13(5):707-714. PubMed ID: 29391287
[TBL] [Abstract][Full Text] [Related]
8. Large-cell neuroendocrine carcinoma of the gynecologic tract: Prevalence, survival outcomes, and associated factors.
Pang L; Chen J; Chang X
Front Oncol; 2022; 12():970985. PubMed ID: 36457506
[TBL] [Abstract][Full Text] [Related]
9. Double-edged role of radiotherapy in patients with pulmonary large-cell neuroendocrine carcinoma.
Jiang Y; Lei C; Zhang X; Cui Y; Che K; Shen H
J Cancer; 2019; 10(25):6422-6430. PubMed ID: 31772675
[No Abstract] [Full Text] [Related]
10. Large Cell Neuroendocrine Tumor Size >3 cm Negatively Impacts Long-Term Outcomes After R0 Resection.
Cattoni M; Vallières E; Brown LM; Sarkeshik AA; Margaritora S; Siciliani A; Filosso PL; Guerrera F; Imperatori A; Rotolo N; Farjah F; Wandell G; Costas K; Mann C; Hubka M; Kaplan S; Farivar AS; Aye RW; Louie BE
World J Surg; 2019 Jul; 43(7):1712-1720. PubMed ID: 30783763
[TBL] [Abstract][Full Text] [Related]
11. Clinical response of large cell neuroendocrine carcinoma of the lung to perioperative adjuvant chemotherapy.
Saji H; Tsuboi M; Matsubayashi J; Miyajima K; Shimada Y; Imai K; Kato Y; Usuda J; Kajiwara N; Uchida O; Ohira T; Hirano T; Mukai K; Kato H; Ikeda N
Anticancer Drugs; 2010 Jan; 21(1):89-93. PubMed ID: 19770636
[TBL] [Abstract][Full Text] [Related]
12. Surgery Versus Chemotherapy and Radiotherapy For Early and Locally Advanced Small Cell Lung Cancer: A Propensity-Matched Analysis of Survival.
Wakeam E; Acuna SA; Leighl NB; Giuliani ME; Finlayson SRG; Varghese TK; Darling GE
Lung Cancer; 2017 Jul; 109():78-88. PubMed ID: 28577955
[TBL] [Abstract][Full Text] [Related]
13. Based on the Development and Verification of a Risk Stratification Nomogram: Predicting the Risk of Lung Cancer-Specific Mortality in Stage IIIA-N2 Unresectable Large Cell Lung Neuroendocrine Cancer Compared With Lung Squamous Cell Cancer and Lung Adenocarcinoma.
Yang Y; Shen C; Shao J; Wang Y; Wang G; Shen A
Front Oncol; 2022; 12():825598. PubMed ID: 35847910
[TBL] [Abstract][Full Text] [Related]
14. Clinical features and treatment outcomes of resected large cell neuroendocrine carcinoma of the lung.
Moon JY; Choi SH; Kim TH; Lee J; Pyo JH; Kim YT; Lee SJ; Yoon HI; Cho J; Lee CG
Radiat Oncol J; 2021 Dec; 39(4):288-296. PubMed ID: 34986550
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of perioperative chemotherapy for pulmonary high-grade neuroendocrine carcinomas: a propensity score matching analysis.
Ogawa H; Tanaka Y; Kitamura Y; Shimizu N; Doi T; Hokka D; Tane S; Nishio W; Yoshimura M; Maniwa Y
J Thorac Dis; 2019 Apr; 11(4):1145-1154. PubMed ID: 31179056
[TBL] [Abstract][Full Text] [Related]
16. Mediastinal lymph node clearance after docetaxel-cisplatin neoadjuvant chemotherapy is prognostic of survival in patients with stage IIIA pN2 non-small-cell lung cancer: a multicenter phase II trial.
Betticher DC; Hsu Schmitz SF; Tötsch M; Hansen E; Joss C; von Briel C; Schmid RA; Pless M; Habicht J; Roth AD; Spiliopoulos A; Stahel R; Weder W; Stupp R; Egli F; Furrer M; Honegger H; Wernli M; Cerny T; Ris HB
J Clin Oncol; 2003 May; 21(9):1752-9. PubMed ID: 12721251
[TBL] [Abstract][Full Text] [Related]
17. Distinct clinicopathologic features, genomic characteristics and survival of central and peripheral pulmonary large cell neuroendocrine carcinoma: From different origin cells?
Zhou F; Hou L; Ding T; Song Q; Chen X; Su C; Li W; Gao G; Ren S; Wu F; Fan J; Wu C; Zhang J; Zhou C
Lung Cancer; 2018 Feb; 116():30-37. PubMed ID: 29413048
[TBL] [Abstract][Full Text] [Related]
18. High-Grade Gastrointestinal Neuroendocrine Carcinoma Management and Outcomes: A National Cancer Database Study.
Alese OB; Jiang R; Shaib W; Wu C; Akce M; Behera M; El-Rayes BF
Oncologist; 2019 Jul; 24(7):911-920. PubMed ID: 30482824
[TBL] [Abstract][Full Text] [Related]
19. Large cell neuroendocrine carcinoma: retrospective analysis of 24 cases from four oncology centers in Turkey.
Ustaalioglu BBO; Ulas A; Esbah O; Turan N; Bilici A; Demirci U; Alkıs N; Seker M; Oksuzoglu B; Gumus M;
Thorac Cancer; 2013 May; 4(2):161-166. PubMed ID: 28920204
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of immune checkpoint inhibitors in advanced large cell neuroendocrine carcinoma of the lung: A single‑institution experience.
Yan N; Guo S; Zhang Z; Shen S; Li X
Oncol Lett; 2024 Mar; 27(3):135. PubMed ID: 38357477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
